Cargando…
Muscular response to the first three months of deflazacort treatment in boys with Duchenne muscular dystrophy
OBJECTIVE: Duchenne muscular dystrophy (DMD) patients are often treated with glucocorticoids; yet their precise molecular action remains unknown. METHODS: We investigated muscle biopsies from nine boys with DMD (aged: 7,6±2,8 yrs.) collected before and after three months of deflazacort treatment and...
Autores principales: | Jensen, L., Petersson, S.J., Illum, N.O., Laugaard-Jacobsen, H.C., Thelle, T., Jørgensen, L.H., Schrøder, H.D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society of Musculoskeletal and Neuronal Interactions
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5492315/ https://www.ncbi.nlm.nih.gov/pubmed/28574407 |
Ejemplares similares
-
Comparing Deflazacort and Prednisone in Duchenne Muscular Dystrophy
por: Biggar, W. Douglas, et al.
Publicado: (2022) -
Comparison of Serum Pharmacodynamic Biomarkers in Prednisone-Versus Deflazacort-Treated Duchenne Muscular Dystrophy Boys
por: Tawalbeh, Shefa, et al.
Publicado: (2020) -
The Canadian experience with long term deflazacort treatment in Duchenne muscular dystrophy
por: McADAM, LAURA C., et al.
Publicado: (2012) -
Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy
por: Griggs, Robert C., et al.
Publicado: (2016) -
The Effect of Deflazacort Treatment on the Functioning of Skeletal Muscle Mitochondria in Duchenne Muscular Dystrophy
por: Dubinin, Mikhail V., et al.
Publicado: (2020)